Kye & Co Internal & Rehabilita is categorized under Internal Medicine Doctors in Millburn, NJ and active since 2005.
Kye & Co Internal & Rehabilita was established in 2005, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Kye S Chun at the company’s single location by writing to 100 Millburn Avenue, Millburn, New Jersey NJ 07041 or by phoning (973) 763-7600. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Kye & Co Internal & Rehabilita |
| Contact Person: | Kye S Chun |
| Address: | 100 Millburn Avenue, Millburn, New Jersey 07041 |
| Phone Number: | (973) 763-7600 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2005 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Kye & Co Internal & Rehabilita was started in 2005 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Kye S Chun for inquiries that concern Kye & Co Internal & Rehabilita by calling the company number (973) 763-7600, as your correspondence is most welcome. Additionally, the physical location of the single location of Kye & Co Internal & Rehabilita can be found at the coordinates 40.722337,-74.287825 as well as the street address 100 Millburn Avenue in Millburn, New Jersey 07041.
For its online presence, you may visit Kye & Co Internal & Rehabilita’s website at and engage with its social media outlets through on Twitter and on Facebook.